研發(fā)與技術(shù)
R&D and Technology
-
查看詳情 >
緬懷恩師王義翹博士—生在中國、長在美國、服務(wù)全球的工業(yè)生物技術(shù)泰斗
2021 - 2020 年 8 月 29 日，我的博士生導(dǎo)師，麻省理工學(xué)院十二位學(xué)院教授之一、國際生物化工奠基人、美國工程院院士、美...
2021-08-30 -
查看詳情 >
Safety tolerability pharmacokinetics and immunogenicity of a monoclonal antibody (SCTA01) targeting SARS-CoV-2 in healthy adults: A randomized double-blind placebo-controlled phase I study
2021 - SCTA01 is a novel monoclonal antibody with promising prophy...
2021-08-30 -
查看詳情 >
The first Chinese national standards for SARS-CoV- neutralizing antibody
2021 - In order to meet the domestic urgent needs of evaluating th...
2021-08-30 -
查看詳情 >
Pharmacokinetic efficacy and safety evaluation of B-domain-deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A
2021 - Introduction: SCT800 is a recombinant human B-domain-delete...
2021-08-30 -
查看詳情 >
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
2020 - The COVID-19 pandemic caused by the SARS-CoV-2 virus has re...
2020-08-29 -
查看詳情 >
Quantification of SARS-CoV-2 antigen levels in the blood of patients with COVID-19
2022 - Bin Su Jiming Yin Xingguang Lin Tiantian Zhang Xiao Yao Yin...
2020-08-24 -
查看詳情 >
Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
2021 - Ling Zhu Yong-Qiang Deng Rong-Rong Zhang Zhen Cui Chun-Yun ...
2020-08-24